Are Mushroom Gummies Safe? The Honest Answer Is: It Depends on the Product
The mushroom gummy category in 2026 contains a wide range of products — from well-documented functional mushroom supplements with transparent lab testing to poorly labeled products that have been linked to hospitalizations. Treating the entire category as safe or unsafe misses the point. The question is how to tell the difference.
This guide covers what federal researchers have documented about safety problems in the category, what a legitimate mushroom gummy’s documentation should look like, and what specific steps buyers can take before purchasing any product in this space.
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before using any dietary supplement. Not for use by persons under 21.
What Federal Research Has Documented
In 2024, researchers at the University of Virginia’s Blue Ridge Poison Center published findings in the CDC’s Morbidity and Mortality Weekly Report after five people — including a three-year-old child — required hospital treatment following ingestion of mushroom gummies. The team tested five brands marketed as mushroom nootropics. Three of the five contained psilocybin or psilocin — both Schedule I controlled substances — that were not disclosed on the label. Additional undisclosed ingredients found across brands included caffeine, ephedrine, and kratom.
That finding is the baseline context for any honest discussion of mushroom gummy safety. The problem is not functional mushrooms themselves. The problem is a subset of the market where labeling does not reflect contents, and where QR codes claiming lab verification have been found to be inaccurate.
A separate, more severe incident involves Diamond Shruumz. The FDA issued a safety warning after the product was linked to more than 70 hospitalizations and at least three potential deaths. Testing revealed undisclosed synthetic psychedelic compounds, a prescription anticonvulsant, muscimol, and ibotenic acid in the product — none of which appeared on its label.
How Functional Mushroom Products Differ from the Problem Category
The products flagged in the UVA research and the Diamond Shruumz recall shared a common characteristic: vague or misleading labeling combined with inadequate third-party testing infrastructure. Products built on verified functional mushroom blends — Lion’s Mane, Reishi, Cordyceps, Chaga — with named third-party labs, recent batch-specific COAs, and transparent Supplement Facts panels occupy a different part of this market.
The distinction isn’t marketing. It’s verifiable. A product with a public COA from a named, licensed third-party lab that specifically screens for controlled substances is meaningfully different from a product with a vague “lab tested” badge and no accessible documentation.
How to Read a Mushroom Gummy COA
A Certificate of Analysis is a lab report issued by a third-party testing facility confirming what a product contains and — critically — what it doesn’t contain. Here’s what to verify when reviewing one for any mushroom gummy product:
Lab identity: The COA should name a specific, verifiable testing laboratory with its own website and accreditation credentials. “Tested in our facility” is not a COA. An unattributed PDF with a logo is not sufficient.
Batch specificity: The COA should reference a specific batch or lot number that corresponds to the product you’re purchasing. A COA from 2023 does not cover a 2025 production batch.
Controlled substance screening: In this category specifically, the COA should confirm negative results for psilocybin and psilocin — not merely confirm the presence of the listed functional mushroom ingredients. A COA that only identifies what’s supposed to be in the product without screening for what shouldn’t be there is substantially less useful.
Contaminant panels: Better COAs also screen for heavy metals, pesticide residues, and microbial contamination. These panels indicate a more comprehensive quality control process.
Who Should Not Use Mushroom Gummies
Even well-documented functional mushroom supplements are not appropriate for everyone. The following groups should consult a physician before using any mushroom supplement product:
Pregnant or nursing individuals — research on functional mushroom safety during pregnancy is insufficient to establish safety. People taking immunosuppressant medications — Reishi in particular has documented immune-modulating effects that could interact with immunosuppressive drugs. People with bleeding disorders or scheduled for surgery — some mushroom compounds have anticoagulant properties. People with autoimmune conditions — the immune-modulating properties of several functional mushrooms may affect conditions like lupus, rheumatoid arthritis, or multiple sclerosis.
High-potency gummy formats like Shrumfuzed — delivering 800mg of concentrated mushroom blend per serving — carry stronger precautions than low-dose daily capsule supplements. The brand’s 21+ age requirement and physician consultation guidance are there for a reason.
Applying This to Shrumfuzed Specifically
Shrumfuzed’s verified label lists four legal functional mushrooms. The brand states third-party testing is conducted and makes lab reports available on its website. Its Supplement Facts panel explicitly excludes psilocybin, Amanita muscaria, and THC from its ingredient declarations.
That documentation puts Shrumfuzed in a different category from the products that triggered federal safety warnings. It does not make any mushroom gummy product zero-risk for all individuals — but it does mean the buyer can verify the product’s documentation rather than relying on marketing claims alone.
For a full breakdown of what’s on Shrumfuzed’s label and what each ingredient does, see: Shrumfuzed Ingredients: A Closer Look at the Four-Mushroom Blend. For an overall product evaluation, see: Shrumfuzed Review 2026: Ingredients, Effects, and What the Label Actually Says.
Frequently Asked Questions
Are mushroom gummies legal?
Mushroom gummies made from functional mushrooms — Lion’s Mane, Reishi, Cordyceps, Chaga, and similar species — are legal dietary supplements in the United States. Products containing psilocybin, psilocin, or Amanita muscaria are in a separate legal category and carry different risks.
Can mushroom gummies cause a failed drug test?
Standard drug tests do not screen for functional mushroom compounds. However, if a product contains undisclosed ingredients — a documented problem in some unverified brands — there is no way to predict the outcome. Purchasing from brands with publicly verifiable third-party lab reports reduces this risk.
What should I look for in a mushroom gummy COA?
Verify the lab is a named, accredited third-party facility. Confirm the test date is recent and matches the product batch. Check that the panel specifically screened for psilocybin and psilocin. A COA that only confirms listed ingredients without screening for undisclosed substances is less useful in this category.
What mushroom gummy brands have faced safety issues?
Diamond Shruumz is the most documented case — the FDA issued a safety warning in 2024 after the product was linked to hospitalizations and potential deaths. Testing revealed undisclosed synthetic compounds and prescription medications. Other brands with non-transparent labeling have been flagged by poison control researchers for undisclosed controlled substance content.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before using any dietary supplement.
Leave a Reply